Overview
SILO market data
Price History
SILO price chart · 1M
- O
- 2.55
- H
- 2.55
- L
- 2.51
- C
- 2.51
- Vol
- 952.00
- Source
- US equities market feed
- Observed
- Aug 26, 2026, 12:00 AM
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $2.55
- Previous Close
- $2.57
- Day High
- $2.55
- Day Low
- $2.51
- 52 Week High
- $7.77
- 52 Week Low
- $2.49
- 7 Day Return
- -9.06%
- 30 Day Return
- -44.10%
- 90 Day Return
- -61.37%
- 1 Year Return
- -62.41%
- Daily Notional Volume
- $2.4K Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$7.57 Diluted earnings per share over the trailing twelve months.
- Beta
- -35.09 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -6,715.7% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $2.46 – $15.15 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $4.2M · P/B 0.72 · P/S 58.01.
Company News
Silo Pharma Enters Asset Purchase Agreement With Parkview Consulting On August 18, 2026; Issues 165,000 Shares As Consideration For Asset PurchaseBenzinga · Aug 19, 2026, 9:21 PM
8-K filing — Silo Pharma, Inc. (SILO)SEC EDGAR · Aug 19, 2026, 9:17 PM
12 Health Care Stocks Moving In Wednesday's Pre-Market SessionBenzinga · Aug 19, 2026, 12:07 PM
12 Health Care Stocks Moving In Tuesday's After-Market SessionBenzinga · Aug 18, 2026, 9:06 PM
Silo Pharma Says Canadian Intellectual Property Office Issues Notice Of Allowance For Patent Application Covering SPC-15, Intranasal 5-HT4 Receptor Agonist Targeting PTSD And Other Stress-Induced Psychiatric DisordersBenzinga · Aug 18, 2026, 8:16 PM
President Trump Say In A Social Media Post That The University Of Miami Shared Its 1994 Ibogaine Investigational New Drug Application With The Government, Which Will Help Accelerate Development As A Medical Treatment In The U.S.Benzinga · Aug 18, 2026, 5:35 PM
Silo Pharma Says EPO Grants Patent Covering Preventative Approach Of Lead Candidate SPC-15, Intranasal, Nose-To-Brain Treatment Targeting PTSD And Stress-Induced Affective DisordersBenzinga · Aug 10, 2026, 12:17 PM
12 Health Care Stocks Moving In Friday's After-Market SessionBenzinga · Aug 7, 2026, 9:05 PM
Silo Pharma Subsidiary QwikAgents Collaborates with Amazon Web Services Premier Tier Partner Caylent to Advance Enterprise AI PlatformGlobenewswire Inc · Aug 6, 2026, 1:16 PM
Silo Pharma’s QwikAgents Engages AWS Premier Tier Services Partner Caylent To Design And Build AWS-Native QwikAgents PlatformBenzinga · Aug 6, 2026, 12:52 PM